These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1804798)

  • 1. Accelerated response to reinoculation in experimental allergic encephalomyelitis: clinical study.
    Levine S; Saltzman A
    Int Arch Allergy Appl Immunol; 1991; 96(3):259-62. PubMed ID: 1804798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated response to reinoculation in experimental allergic encephalomyelitis: histopathologic study.
    Levine S; Saltzman A
    J Neuropathol Exp Neurol; 1991 Mar; 50(2):126-33. PubMed ID: 1707089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperacute form of allergic encephalomyelitis produced in rats without the aid of pertussis vaccine.
    Levine S; Saltzman A
    J Neuropathol Exp Neurol; 1989 May; 48(3):255-62. PubMed ID: 2784830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks.
    Levine S; Sowinski R
    Am J Pathol; 1980 Nov; 101(2):375-86. PubMed ID: 7435544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats.
    Levine S; Sowinski R
    J Immunol; 1975 Feb; 114(2 Pt 1):597-601. PubMed ID: 1120901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY; Harvey JM; Webster LT
    J Immunol; 1977 Jun; 118(6):2151-4. PubMed ID: 301156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental allergic encephalomyelitis by EN3638: dependence on adjuvants and treatment schedules.
    Levine S; Sowinski R
    J Immunopharmacol; 1979; 1(4):547-57. PubMed ID: 401321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
    Weber F; Hempel K
    Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS WITHOUT THE AID OF ADJUVANT.
    LEVINE S; WENK EJ
    Ann N Y Acad Sci; 1965 Mar; 122():209-26. PubMed ID: 14313479
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid induction of allergic encephalomyelitis in rats without the use of mycobacteria.
    BELL J; PATERSON PY
    Science; 1960 May; 131(3411):1448. PubMed ID: 13798502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant potential of vitamin E in the induction of experimental allergic encephalomyelitis: histological aspects].
    Felaco M; Arduini A; Guanciali Franchi P; Cesario G; Palka G; Federici G
    Boll Soc Ital Biol Sper; 1984 Aug; 60(8):1629-33. PubMed ID: 6333882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
    Kennedy MK; Dal Canto MC; Trotter JL; Miller SD
    J Immunol; 1988 Nov; 141(9):2986-93. PubMed ID: 2459237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.
    Staykova MA; Liñares D; Fordham SA; Paridaen JT; Willenborg DO
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):543-54. PubMed ID: 18520773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALLERGIC ENCEPHALOMYELITIS: A HYPERACUTE FORM.
    LEVINE S; WENK EJ
    Science; 1964 Dec; 146(3652):1681-2. PubMed ID: 14224517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by prostaglandin synthesis inhibition.
    Weber F; Hempel K
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):242-5. PubMed ID: 2474512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.